{"version":"1.0","provider_name":"The Catapult Network","provider_url":"https:\/\/catapult.org.uk","author_name":"india campbell","author_url":"https:\/\/catapult.org.uk\/author\/india-campbellcatapultnetwork-org-uk\/","title":"Delivering safer advanced therapies, faster and at lower cost through technology and process innovation - The Catapult Network","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"PYWP9SHQ1s\"><a href=\"https:\/\/catapult.org.uk\/our-work\/case-studies\/delivering-safer-advanced-therapies-faster-and-at-lower-cost-through-technology-and-process-innovation\/\">Delivering safer advanced therapies, faster and at lower cost through technology and process innovation<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/catapult.org.uk\/our-work\/case-studies\/delivering-safer-advanced-therapies-faster-and-at-lower-cost-through-technology-and-process-innovation\/embed\/#?secret=PYWP9SHQ1s\" width=\"600\" height=\"338\" title=\"&#8220;Delivering safer advanced therapies, faster and at lower cost through technology and process innovation&#8221; &#8212; The Catapult Network\" data-secret=\"PYWP9SHQ1s\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/catapult.org.uk\/wp-content\/uploads\/2022\/08\/CGTC-priorty-3TPI-2-scaled.jpg","thumbnail_width":3840,"thumbnail_height":2565,"description":"At its core, Cell and Gene Therapy Catapult is an innovation and technology company. Its work with industry in the development of novel processes and analytical techniques for cell and gene therapy manufacture has supported significant investment into startup businesses as well as attracting international manufacturers such as Rentschler to invest in manufacturing in the UK."}